Gender | Signs and Symptoms Myocardial Ischemia | Chest Pain | Cardiac stress test abnormal | Testing Noninvasive Abnormal | Coronary Artery Disease Obstructive Absent | Coronary Stenosis Epicardial | Percent Diameter Stenosis Measurement Luminal
Item
1. women with signs and symptoms of myocardial ischemia (chest pain, abnormal stress testing, abnormal noninvasive testing) in the absence of obstructive coronary artery disease (epicardial coronary stenosis <50% luminal diameter stenosis).
boolean
C0079399 (UMLS CUI [1])
C0037088 (UMLS CUI [2,1])
C0151744 (UMLS CUI [2,2])
C0008031 (UMLS CUI [3])
C1096350 (UMLS CUI [4])
C0039593 (UMLS CUI [5,1])
C2986496 (UMLS CUI [5,2])
C0205161 (UMLS CUI [5,3])
C1956346 (UMLS CUI [6,1])
C0549186 (UMLS CUI [6,2])
C0332197 (UMLS CUI [6,3])
C0242231 (UMLS CUI [7,1])
C0442016 (UMLS CUI [7,2])
C3897965 (UMLS CUI [8,1])
C0524462 (UMLS CUI [8,2])
Gender | Myocardial Ischemia Percentage | Cardiovascular magnetic resonance imaging Perfusion
Item
2. women with ≥10% myocardial ischemia by cmr perfusion.
boolean
C0079399 (UMLS CUI [1])
C0151744 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C3873775 (UMLS CUI [3,1])
C0428857 (UMLS CUI [3,2])
Medical contraindication Nitrates | Medical contraindication Adrenergic beta-Antagonists | Medical contraindication Calcium Channel Blockers | Medical contraindication Angiotensin-Converting Enzyme Inhibitors | Medical contraindication Angiotensin II receptor antagonist
Item
1. contraindications to withholding nitrates, beta-blockers, calcium channel agents, ace/arb agents for 48 hours prior to testing.
boolean
C1301624 (UMLS CUI [1,1])
C0028125 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0001645 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0006684 (UMLS CUI [3,2])
C1301624 (UMLS CUI [4,1])
C0003015 (UMLS CUI [4,2])
C1301624 (UMLS CUI [5,1])
C0521942 (UMLS CUI [5,2])
Medical contraindication Cardiovascular magnetic resonance imaging | Automatic Implantable Cardioverter-Defibrillators | Artificial cardiac pacemaker | Claustrophobia Treating Unsuccessful | Angioedema
Item
2. contraindications in cmr including aicd, pacemaker, untreatable claustrophobia or known angio-edema.
boolean
C1301624 (UMLS CUI [1,1])
C3873775 (UMLS CUI [1,2])
C0972395 (UMLS CUI [2])
C0030163 (UMLS CUI [3])
C0008909 (UMLS CUI [4,1])
C1522326 (UMLS CUI [4,2])
C1272705 (UMLS CUI [4,3])
C0002994 (UMLS CUI [5])
Medical contraindication ranolazine | Hepatic Insufficiency | Prolonged QT interval | Kidney Failure
Item
3. contraindications to ranolazine including hepatic insufficiency, prolonged qt, renal failure.
boolean
C1301624 (UMLS CUI [1,1])
C0073633 (UMLS CUI [1,2])
C1306571 (UMLS CUI [2])
C0151878 (UMLS CUI [3])
C0035078 (UMLS CUI [4])
Gender | CYP3A Inhibitors | Diltiazem | Verapamil | Ketoconazole | Macrolides | HIV Protease Inhibitors
Item
4. women taking drugs that inhibit cyp3a such as diltiazem, verapamil, ketoconazole, macrolides or hiv protease inhibitors.
boolean
C0079399 (UMLS CUI [1])
C3850056 (UMLS CUI [2])
C0012373 (UMLS CUI [3])
C0042523 (UMLS CUI [4])
C0022625 (UMLS CUI [5])
C0282563 (UMLS CUI [6])
C0162714 (UMLS CUI [7])
Gender | Age
Item
5. women less than 18 years of age.
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Gender | Pharmaceutical Preparations Causing Prolonged QT interval | Anti-Arrhythmia Agents Class | Erythromycin | Antipsychotic Agents
Item
6. women on drugs that prolong the qt interval such as class ia or iii antiarrhythmic agents, erythromycin, certain antipsychotics.
boolean
C0079399 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C0678227 (UMLS CUI [2,2])
C0151878 (UMLS CUI [2,3])
C0003195 (UMLS CUI [3,1])
C0456387 (UMLS CUI [3,2])
C0014806 (UMLS CUI [4])
C0040615 (UMLS CUI [5])
Pregnancy | Breast Feeding
Item
7. pregnancy or breast feeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Life Expectancy
Item
8. life expectancy less than 6 months.
boolean
C0023671 (UMLS CUI [1])